Betanil, or Mirabelone Extended-Release Tablets, is used for the treatment of overactive bladder syndrome and should be used as prescribed by your doctor.
Mirabelone extended-release tablets belong to a beta 3 adrenergic receptor agonist, which acts on the bladder tissue to relax the smooth muscles of the bladder. It is used for the symptomatic treatment of urinary frequency, urgency, and urge incontinence in adults with overactive bladder.
Adverse reactions to Mirabelone Extended-Release Tablets can be seen as urinary tract infections, tachycardia, nausea, diarrhea, constipation, headache, dizziness, vaginal infections, cystitis, palpitations (rapid heartbeat, often accompanied by panic), and atrial fibrillation.
Mirabelone Extended-Release Tablets are contraindicated in people who are allergic to Mirabelone and people with poorly controlled severe hypertension. The medication should be used reasonably under the guidance of a doctor to avoid aggravating the condition.